HF
PPBT

HRT Financial’s Purple Biotech PPBT Stock Holding History

HRT Financial’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24K Buy
+14,640
New +$49.4K ﹤0.01% 3906
2024
Q3 		– Sell
-69
Closed -$5K – 2982
2024
Q2 		$5K Buy
+69
New +$8K ﹤0.01% 2042

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
IA
IFG Advisory Atlanta, Georgia $2.85B AUM 26.07% 1-Year Est. Return

HRT Financial's PPBT Position: Q2 2026 in Review

HRT Financial opened a new position in Purple Biotech (PPBT) in Q2 2026: 14,640 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #3906 among its holdings. This is a return to the name: HRT Financial previously reported a position in PPBT as recently as Q2 2024.

HRT Financial first reported a position in PPBT in Q2 2024 and has held it in 2 quarters since. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • HRT Financial held 14,640 shares of Purple Biotech worth $24K as of Q2 2026.
  • Purple Biotech was a new HRT Financial position in Q2 2026.
  • Purple Biotech made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3906 holding.
  • HRT Financial first reported a position in Purple Biotech in Q2 2024 and has held it in 2 quarters since.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.